Why your employer has more control than you might think
If you have employer-sponsored insurance and your company is "self-funded" (meaning it pays employee healthcare claims directly rather than fully outsourcing risk to an insurer), your employer — not just the insurance carrier — has direct authority over whether GLP-1 medications are covered, and under what conditions. This is a distinct decision-making process from the state and federal policy questions covered in our related guides on state coverage mandates and Medicare coverage.
How the decision actually gets made internally
- Benefits consultants and brokers typically model the projected cost of adding GLP-1 coverage against expected claims data, presenting options (full coverage, coverage with strict prior authorization/BMI criteria, coverage only for diabetes, or exclusion) to the employer.
- HR and finance leadership weigh that projected cost against budget, competitive positioning (whether peer companies in the same industry offer this benefit), and employee demand.
- The decision is typically finalized annually, ahead of open enrollment, meaning there's a real window each year when this is actively being reconsidered — not a permanent, unchangeable policy.
How to make a credible case as an employee
- Time your ask before renewal season, typically several months before open enrollment, when benefits decisions are actively being modeled rather than already locked in.
- Go through the right channel — usually HR or a benefits committee, not your individual manager. Some companies have an employee benefits survey or suggestion process specifically for this.
- Frame the ask around retention and productivity, not just personal need. Employers respond to business cases: reduced absenteeism, -related healthcare costs, and competitive benefits positioning against peer employers, alongside the human case.